RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
BLOOD
Collezione ASL Torino 4

Items : 9

Beyond genotype: challenges in predicting disease risk for carriers of biallelic perforin variants. in Blood / Blood. 2025 Mar 16:blood.2024027954. doi: 10.1182/blood.2024027954.

2025
ASL Torino 4

Wegehaupt O; Borisov O; Sieni E; Oyen F; Mann J; Coniglio ML; Chinnici A PhD; Pegoraro F; Beneforti L; Gilmour KC; Moshous D; de Saint Basile G; Zhang W; Marsh RA; De Fusco C; Wustrau K; Timeus F; Micalizzi C; Gunsilius E; Hosking L; Choo S; Ghosh S; Köttgen A; Lehmberg K; Ehl S;

Baseline Characteristics from Arise Study, an Italian Non-Interventional Study Assessing the Real-World Use of Acalabrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL) in Blood

2024
ASL Torino 4

Mauro FR; Visentin A; Laurenti L; Gallo S; Pavone V; Nicoli P; Postorino M; Scortechini I; Scarfo L; Foglietta M; Borella C; Palumbo G; Di Rienzo N; Tani M; Tafuri A; Sportoletti P; Scalzulli PR; Pennese E; Pastore D; Pasquini C; Malandruccolo L; Di Veroli A; De Santis G; Catania G; Tamburini A; Stelitano C; Pane F; Musto P; Magagnoli M; et alii...

Rituximab and Lenalidomide (R 2) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL) in Blood

2023
ASL Torino 4

Boccomini C; Botto B; Evangelista A; Zilioli VR; Anastasia A; Cavallo F; Merli F; Zanni M; Tani M; Chiarenza A; Liberati AM; Conconi A; Corradini P; Bari A; Annechini G; Gaidano G; Spina M; Sartori R; Castellino C; Puccini B; Arcari A; Bigliardi S; Matta G; Merli M; Mannina D; Marino D; Galieni P; Ciambelli F; Musuraca G; et alii...

Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS) in Blood

2022
ASL Torino 4
ASL Biella

Lanino L; Salutari P; Perego A; Fattizzo B; Riva M; Ubezio M; Musto P; Cilloni D; Oliva EN; Voso MT; Pelizzari AM; Poloni A; Capodanno I; Elena C; Fozza C; Pane F; Breccia M; De Gobbi M; Di Bassiano F; Barraco D; Crisà E; Ferrero D; Frairia C; Vaccarino A; Griguolo D; Paolini S; Quintini M; Sessa M; Turrini M; et alii...

Sparing anti-bacterial prophylaxis in acute myeloid leukemia during post induction aplasia does not impact on bacteriemiae incidence and early death: A retrospective single center study in Blood

2018
ASL Torino 4

Frairia C; Urbino I; Audisio E; Aydin S; D'Ardia S; Emanuela M; Iovino G; Nicolino B; Vitolo U;

Mantle cell lymphoma mimicking mucosa-associated lymphoid tissue (MALT) lymphomas: A pathological characterization (on behalf of the “fondazione italiana linfomi (FIL)-postgraduate master course”) in Blood

2017
ASL Torino 4

Rattotti S; Croci G; Morello L; Marino D; Carli G; Ferrero S; Loseto G; Olivieri J; Pelosini M; Sgherza N; Calimeri T; Giannoccaro M; Fama A; Mosna F; Tisi MC; Tomei G; Mazzone AM; Arcaini L; Zaja F; Paulli M;

Prognostic value of serum ferritin, transferrin saturation and C-reactive protein at diagnosis in myelodysplastic syndrome patients: Analysis of patients from the MDS piedmont registry in Blood

2011
ASL Torino 4

Messa E; Gioia D; Bertassello C; Ciccone G; Evangelista A; Manuela C; Allione B; Cilloni D; Salvi F; Cametti G; Lunghi M; Ferrero D; Falco P; Bonferroni M; Saglio G; Levis A;

Comparison among citology, histology, and flow cytometry in evaluating blast values in myelodysplatic syndromes (MDS). Survey from the Italian “Piemonte MDS registry” in Blood

2010
ASL Torino 4

Levis A; Gioia DM; Godio L; Girotto M; Allione B; Bertassello C; Bonferroni M; Ciriello MM; Cametti G; Ciravegna G; Ferranti A; Lunghi M; Ferrero D; Freilone R; Gatto S; Salvi F; Savio M; Scaravaglio P; Stacchini A; Tonso A; Boccadoro M; Gaidano G; Gallamini A; Vitolo U; Saglio G;

A multicenter, open label study of oral lenalidomide and prednisone (RP) followed by oral lenalidomide melphalan and prednisone (MPR) and oral lenalidomide maintenance in newly diagnosed elderly multiple myeloma patients in Blood

2010
ASL Torino 4

Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Siez MLM; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M;